Mixture-of-Experts Approach for Enhanced Drug-Target Interaction Prediction and Confidence Assessment

bioRxiv Pub Date : 2024-08-08 DOI:10.1101/2024.08.06.606753
Yijingxiu Lu, Sangseon Lee, Soosung Kang, Sun Kim
{"title":"Mixture-of-Experts Approach for Enhanced Drug-Target Interaction Prediction and Confidence Assessment","authors":"Yijingxiu Lu, Sangseon Lee, Soosung Kang, Sun Kim","doi":"10.1101/2024.08.06.606753","DOIUrl":null,"url":null,"abstract":"In recent years, numerous deep learning models have been developed for drug-target interaction (DTI) prediction. These DTI models specialize in handling data with distinct distributions and features, often yielding inconsistent predictions when applied to unseen data points. This inconsistency poses a challenge for researchers aiming to utilize these models in downstream drug development tasks. Particularly in screening potential active compounds, providing a ranked list of candidates that likely interact with the target protein can guide scientists in prioritizing their experimental efforts. However, achieving this is difficult as each current DTI model can provide a different list based on its learned feature space. To address these issues, we propose EnsDTI, a Mixture-of-Experts architecture designed to enhance the performance of existing DTI models for more reliable drug-target interaction predictions. We integrate an inductive conformal predictor to provide confidence scores for each prediction, enabling EnsDTI to offer a reliable list of candidates for a specific target. Empirical evaluations on four benchmark datasets demonstrate that EnsDTI not only improves DTI prediction performance with an average accuracy improvement of 2.7% compared to the best performing baseline, but also offers a reliable ranked list of candidate drugs with the highest confidence, showcasing its potential for ranking potential active compounds in future applications. CCS CONCEPTS • Applied computing → Bioinformatics; • Computing methodologies → Artificial intelligence.","PeriodicalId":505198,"journal":{"name":"bioRxiv","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2024-08-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"bioRxiv","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1101/2024.08.06.606753","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

In recent years, numerous deep learning models have been developed for drug-target interaction (DTI) prediction. These DTI models specialize in handling data with distinct distributions and features, often yielding inconsistent predictions when applied to unseen data points. This inconsistency poses a challenge for researchers aiming to utilize these models in downstream drug development tasks. Particularly in screening potential active compounds, providing a ranked list of candidates that likely interact with the target protein can guide scientists in prioritizing their experimental efforts. However, achieving this is difficult as each current DTI model can provide a different list based on its learned feature space. To address these issues, we propose EnsDTI, a Mixture-of-Experts architecture designed to enhance the performance of existing DTI models for more reliable drug-target interaction predictions. We integrate an inductive conformal predictor to provide confidence scores for each prediction, enabling EnsDTI to offer a reliable list of candidates for a specific target. Empirical evaluations on four benchmark datasets demonstrate that EnsDTI not only improves DTI prediction performance with an average accuracy improvement of 2.7% compared to the best performing baseline, but also offers a reliable ranked list of candidate drugs with the highest confidence, showcasing its potential for ranking potential active compounds in future applications. CCS CONCEPTS • Applied computing → Bioinformatics; • Computing methodologies → Artificial intelligence.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
用于增强药物-靶点相互作用预测和可信度评估的专家混合方法
近年来,针对药物靶点相互作用(DTI)预测开发了大量深度学习模型。这些 DTI 模型擅长处理具有不同分布和特征的数据,但在应用于未见数据点时,往往会产生不一致的预测结果。这种不一致性给希望在下游药物开发任务中利用这些模型的研究人员带来了挑战。特别是在筛选潜在活性化合物时,提供一份可能与目标蛋白质发生相互作用的候选化合物排序列表可以指导科学家确定实验工作的优先顺序。然而,要做到这一点并不容易,因为目前的每个 DTI 模型都能根据其学习到的特征空间提供不同的列表。为了解决这些问题,我们提出了 EnsDTI,这是一种专家混合物架构,旨在提高现有 DTI 模型的性能,从而进行更可靠的药物-目标相互作用预测。我们整合了一个归纳保形预测器,为每个预测提供置信度分数,使 EnsDTI 能够为特定靶标提供可靠的候选列表。在四个基准数据集上进行的实证评估表明,EnsDTI不仅提高了DTI预测性能,与性能最好的基线相比,平均准确率提高了2.7%,而且还提供了可信度最高的候选药物列表,展示了它在未来应用中对潜在活性化合物进行排序的潜力。CCS 概念 - 应用计算 → 生物信息学; - 计算方法 → 人工智能。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Stability of cross-sensory input to primary somatosensory cortex across experience Genomic re-sequencing reveals mutational divergence across genetically engineered strains of model archaea A principled approach to community detection in interareal cortical networks A minimal mathematical model for polarity establishment and centralsplindlin-independent cytokinesis PTEN neddylation aggravates CDK4/6 inhibitor resistance in breast cancer
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1